Risk categories and refractory CLL in the era of chemoimmunotherapy

Risk categories and refractory CLL in the era of chemoimmunotherapy

This full paper has just become available and it is an important topic, unfortunately.

'Refractory CLL has been defined as no response or response lasting < 6 months from last therapy. This subgroup has a very poor outcome, and many trials use this group

as an entry point for early drug development.'

PDF File bloodjournal.hematologylibr...

Last edited by
oldestnewest

You may also like...